Kolar Z - Search Results

1

The synthetic ligand of peroxisome proliferator-activated receptor-gamma ciglitazone affects human glioblastoma cell lines.

Strakova N, Ehrmann J, Dzubak P, Bouchal J, Kolar Z. Strakova N, et al. Among authors: kolar z. J Pharmacol Exp Ther. 2004 Jun;309(3):1239-47. doi: 10.1124/jpet.103.063438. Epub 2004 Feb 26. J Pharmacol Exp Ther. 2004. PMID: 14988421

2

Peroxisome proliferator-activated receptors (PPARs) in health and disease.

Ehrmann J Jr, Vavrusová N, Collan Y, Kolár Z. Ehrmann J Jr, et al. Among authors: kolar z. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2002 Dec;146(2):11-4. doi: 10.5507/bp.2002.002. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2002. PMID: 12572888 Free article. Review.

3

Peroxisome proliferator-activated receptors (PPAR) agonists affect cell viability, apoptosis and expression of cell cycle related proteins in cell lines of glial brain tumors.

Strakova N, Ehrmann J, Bartos J, Malikova J, Dolezel J, Kolar Z. Strakova N, et al. Among authors: kolar z. Neoplasma. 2005;52(2):126-36. Neoplasma. 2005. PMID: 15800711

4

The effects of natural ligands of hormone receptors and their antagonists on telomerase activity in the androgen sensitive prostatic cancer cell line LNCaP.

Bouchal J, Kolár Z, Mad'arová J, Hlobilková A, von Angerer E. Bouchal J, et al. Among authors: kolar z. Biochem Pharmacol. 2002 Mar 15;63(6):1177-81. doi: 10.1016/s0006-2952(01)00927-3. Biochem Pharmacol. 2002. PMID: 11931851

5

Microarray analysis of bicalutamide action on telomerase activity, p53 pathway and viability of prostate carcinoma cell lines.

Bouchal J, Baumforth KR, Sváchová M, Murray PG, von Angerer E, Kolár Z. Bouchal J, et al. Among authors: kolar z. J Pharm Pharmacol. 2005 Jan;57(1):83-92. doi: 10.1211/0022357055164. J Pharm Pharmacol. 2005. PMID: 15638997

6

WWOX, a new potential tumor suppressor gene.

Hezova R, Ehrmann J, Kolar Z. Hezova R, et al. Among authors: kolar z. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2007 Jun;151(1):11-5. doi: 10.5507/bp.2007.002. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2007. PMID: 17690733 Review.

7

Autocrine regulation of glioblastoma cell cycle progression, viability and radioresistance through the VEGF-VEGFR2 (KDR) interplay.

Knizetova P, Ehrmann J, Hlobilkova A, Vancova I, Kalita O, Kolar Z, Bartek J. Knizetova P, et al. Among authors: kolar z. Cell Cycle. 2008 Aug 15;7(16):2553-61. doi: 10.4161/cc.7.16.6442. Epub 2008 Aug 12. Cell Cycle. 2008. PMID: 18719373

8

Platinum(IV) complex LA-12 exerts higher ability than cisplatin to enhance TRAIL-induced cancer cell apoptosis via stimulation of mitochondrial pathway.

Jelínková I, Šafaříková B, Vondálová Blanářová O, Skender B, Hofmanová J, Sova P, Moyer MP, Kozubík A, Kolář Z, Ehrmann J, Hyršlová Vaculová A. Jelínková I, et al. Among authors: kolar z. Biochem Pharmacol. 2014 Dec 1;92(3):415-24. doi: 10.1016/j.bcp.2014.09.013. Epub 2014 Oct 5. Biochem Pharmacol. 2014. PMID: 25285768

9

Synergic effects of the cyclin-dependent kinase (CDK) inhibitor olomoucine and androgen-antagonist bicalutamide on prostatic cancer cell lines.

Knillová J, Bouchal J, Hlobilková A, Strnad M, Kolár Z. Knillová J, et al. Among authors: kolar z. Neoplasma. 2004;51(5):358-67. Neoplasma. 2004. PMID: 15640940

10

Expression of STATs and their inhibitors SOCS and PIAS in brain tumors. In vitro and in vivo study.

Ehrmann J, Strakova N, Vrzalikova K, Hezova R, Kolar Z. Ehrmann J, et al. Among authors: kolar z. Neoplasma. 2008;55(6):482-7. Neoplasma. 2008. PMID: 18999875

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

220 results

Search Page